Needham & Company Downgrades GenMark Diagnostics (GNMK) to Hold, Following Acquisition
Tweet Send to a Friend
Needham & Company analyst Mike Matson downgraded GenMark Diagnostics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
